It is considered that more than three million children around the world have died 2022. from the consequences of antibiotic infections, the research of two leading health professionals showed.
According to the BBC, the children in Africa and Southeast Asia were found to be most endangered.
Antimicrobial resistance – known as amr – develops when microbes that cause infections develop in such a way that antibiotics no longer operate. It was identified as one of the largest threats to public health faced by the world population.
A new study now reveals the tribute that AMr takes on children. Using data from multiple sources, including the World Bank, and the World Bank, the authors of the report calculated that more than three million children’s deaths in 2022. Related to drug resistant infections.
Experts say that this new study emphasizes more than a ten-time increase in AMR-related infections in children in just three years. The number could worsen due to the influence of Covida Pandemic.
Antibiotics are used to treat or prevent a large number of bacterial infections – everything from leather infections to pneumonia. They also sometimes give a precaution to prevent preventing infection – for example if someone has surgery or receiving cancer chemotherapy. However, antibiotics have no impact on viral infections – diseases such as colds, flu or covid.
Some bacteria have now developed resistance to some medications, due to their excessive and inappropriate use, while the production of new antibiotics is a long-lasting and expensive process – slow.
Amr is a global problem
Leading authors reports, doctor Yanhong Jessika HU from the Australian Research Institute in Australia and Professor Harb Harwell from Clinton’s health access initiatives, indicate a significant increase in the use of antibiotics that are intended only to combat the most serious infections.
Between 2019. and 2021. The use of antibiotics with a high risk of resistance, increased by 160% in Southeast Asia and 126% in Africa. During the same period, “reserve antibiotics” – the last refuge for the treatment of severe multi-drug-resistant infections – rose 45% in Southeast Asia and 125% in Africa.
The authors warn that, if bacteria develop resilience to these antibiotics, be small, if they will not be at all, an alternative to the treatment of infections resistant to multiple medications.
Professor Harwell presents the findings at the Congress of the European Society for Clinical Microbiology and Infectious Diseases in Vienna later this month.
“Amr is a global problem. This is how we worked to focus on a disproportionate way in which AMR affects children. We estimate that three million deaths in the world are related to antimicrobial resistance,” said the event.
The WHIM describes the AM as one of the most serious global threats with whom we face, but addressing Vienna, Professor Harwell warns that there are no easy answers.
Dr. Lindsey Edwards, a higher lecturer of microbiology at King’s College in London, said the new study “marks a significant and alarming increase compared to previous data”.
“These discovery should serve as an invitation to the alert for global health leaders. With no determined action, AMR could undermine decades of progress in children’s health, especially in the most sensitive region’s regions,” she warned Zenit.
